Babesia gibsoni P50 antibody and antigen (recombinant protein)

 Download 

Product information

Size： 1mg | 10mg | 100mg

Catalog No.	Description	US $ Price (per mg)	First Order Discount	First Order Discount Price
GMP-VT-P262-Tg001-Ag01	Recombinant Babesia gibsoni P50 protein	3090
GMP-VT-P262-Tg001-Ab01	Anti-Babesia gibsoni P50 mouse monoclonal antibody (mAb)	1953	20%	1562.4
GMP-VT-P262-Tg001-Ab02	Anti-Babesia gibsoni P50 mouse monoclonal antibody (mAb)	1953	20%	1562.4
GMP-VT-P262-Tg001-Ab03	Anti-Babesia gibsoni P50 mouse monoclonal antibody (mAb)	1953	20%	1562.4
GMP-VT-P262-Tg001-Ab04	Anti-Babesia gibsoni P50 mouse monoclonal antibody (mAb)	1953	20%	1562.4

Shipping Costs: $360–$760
Antibodies: $360 Antigens: $760 (Elevated cost due to antigen heterogeneity, post-translational modifications, structural complexity, and specialized handling.)

Product Description

Cat No. of Products	GMP-VT-P262-Tg001-Ag01
Product Name	Recombinant Babesia gibsoni P50 protein
Pathogen	Babesia gibsoni
Target/Biomarker	P50
Expression platform	E.coli
Isotypes	Recombinant Antigen
Bioactivity validation	Anti-Babesia gibsoni P50 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Babesia gibsoni level test of animal Dog/Canine, Bovines/Cattle, Equine/Horse with Babesia gibsoni infection.
Tag	His
Products description	Recombinant Babesia gibsoni P50 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-VT-P262-Tg001-Ab01, GMP-VT-P262-Tg001-Ab02, GMP-VT-P262-Tg001-Ab03, GMP-VT-P262-Tg001-Ab04
Product Name	Anti-Babesia gibsoni P50 mouse monoclonal antibody (mAb)
Pathogen	Babesia gibsoni
Target/Biomarker	P50
Expression platform	CHO
Isotypes	Mouse IgG
Bioactivity validation	Recombinant Babesia gibsoni P50 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Babesia gibsoni antibodies in Babesia gibsoni level test of animal Dog/Canine, Bovines/Cattle, Equine/Horse with Babesia gibsoni infection.
Tag	mFc
Products description	Anti-Babesia gibsoni P50 mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

Click to get more Data / Case study about the product.

Target/Biomarker information

Babesia is a protozoan parasite found to infect vertebrate animals, mostly livestock mammals and birds, but also occasionally humans. Common names of the disease that Babesia microti causes are Texas cattle fever, redwater fever, tick fever, and Nantucket fever.Canine babesiosis is a hemoprotozoan infection typically caused by Babesia canis or Babesia gibsoni. Babesia gibsoni is a tickborne protozoal blood parasite that causes hemolytic anemia, thrombocytopenia, lethargy, and splenomegaly. quine babesiosis in India has always been a severe and life-threatening disease attributed to infection with Theileria equi and Babesia caballi. These organisms are not host-specific, as both T. equi and B. caballi are reported in dogs. Likewise, Babesia canis canis and Babesia canis rossi, the common causative agents in canines, have also been identified in horses. However, no molecular evidence of Babesia gibsoni has been reported in horses in India. A 5-year-old Thoroughbred gelding residing in Bengaluru showed signs of recurrent intermittent fever, inappetence, poor performance, anaemia and depression. A regular complete blood count and biochemical profile were done, however, the results were unresponsive to treatment interventions. The blood sample was submitted for screening equine haemoprotozoans using polymerase chain reaction. The current blood sample was screened for haemoprotozoans. The sample was positive for B. gibsoni and was confirmed by sequencing. Basic Local Alignment Search Tool (BLAST) search against GenBank revealed the highest similarity (95.17%, Accession No. MN385430.1) with B. gibsoni 18s rRNA partial sequence.

About GDU